Medicines in Development

Patients with a wide range of life-threatening and debilitating illnesses today live in the hope tomorrow will bring a new medicine that will improve or even save their life. America’s biopharmaceutical research companies are researching and developing new medicines to meet unmet need and continuing research and development even after U.S. Food and Drug Administration (FDA) approval, all with the goal of improving patients’ health, quality of life, and saving lives.

Since 2000, nearly 900 new medicines have been approved by the FDA, helping patients live longer, healthier lives. Among the remarkable new treatments reaching patients are the first gene therapies for devastating rare genetic disorders impacting infants and children, curative treatments for hepatitis C, a range of CAR-T cell therapies driving unprecedented remission rates for cancer patients as well as immunotherapies and targeted therapies widely regarded as driving accelerated drops in cancer mortality for U.S. patients in recent years.

Explore the medicines in development for a wide range of diseases below.

Medicines in Development for Cancer: 2023 Report

Close-up photograph of an African-American female scientist's blue-gloved hands handling a test tube, with her intently focused expression in focus

Decades of research unlocking the secrets, nature and origin of cancer have led to an unprecedented amount of targeted treatment approaches and improved prognosis for many cancer patients. Today, there are 1,600 treatments and vaccines in clinical development for cancer, more than doubling since 2014.